—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Sanofi ADR (SNY) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for SNY, from the same nightly bakes the boards use. Research diary readings, not advice.

Mentioned on Closelooknet 1 piece · newest: Daily Pulse, “Temperature 59 Risk-On as AW25 Surges 5.3% in Single Session” (2026-04-16)

Mentioned on Closelooknet

Where SNY appears in the diary — 1 piece, newest first. Every link is our own writing.

Dailies

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
How it trades on rate days beta 0.62 to TLT · on the worst bond days it fell more than the market

How it trades on rate days

How SNY has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.62 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Sanofi ADR moved 0.62% on average · correlation 0.25 · higher than 63% of US names
  • Beta, last 3 months 0.97 more rate-sensitive lately than over the year
  • On the 10 worst bond days −1.11% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −1.73% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - General · US · 8 names with week and year-to-date

Peer group

Drug Manufacturers - General · US

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against SNY on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Sanofi ADR

SNY in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Sanofi researches, manufactures and sells medicines and vaccines across immunology, rare neurological disease, oncology and childhood immunisation, including combination vaccines for several infections at once. It also runs a wide set of collaborations with smaller biotech and computational firms, several of them using machine-learning platforms to search for new drug candidates. The company is based in Paris and was known as Sanofi-Aventis before it took its current name.
Where it sits in the stack
Sanofi carries no seat in our index and sits outside the layered AI build-out that our index tracks; it belongs to the pharmaceuticals sleeve of the wider universe the diary follows for its own sake, not as an input to chips, data centres or models.
Who it is priced against
Closelooknet has not assigned it a peer group; the comparison the market usually draws is with other large diversified drugmakers such as Pfizer.
Why Closelooknet tracks it
It holds no seat in our index and no Closelooknet score module has been built for it. It has appeared once in the diary, in a Daily Pulse edition that named it among defensives alongside McDonald's, ExxonMobil and Unilever, with Palantir as the single high-beta name in that session.
What the diary watches
Whether any of its AI-assisted drug-discovery collaborations move from early research into named clinical candidates, which would give the diary a genuine AI angle on the stock rather than a defensive one.

Sanofi ADR (SNY) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 1 analyst action on the wire · latest: initiation by RBC Capital, 2026-09-08

The Street on this name

Analyst actions and the latest print for SNY from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Initiation RBC Capital — at Sector Perform Initiated to Sector Perform 2026-09-08

1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 5.89%, annual · last 2.42 USD on 2026-05-04

Dividends and capital return

What SNY pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.42 USD per share · a 5.89% yield on the 2026-09-25 close 1 distribution, paid once a year 2026-09-25
  • Change on the year +9.5% against the prior twelve months prior twelve months 2.21 USD per share
  • Last distribution 2.42 USD per share as the price series records it, within days of the ex-date 2026-05-04
  • By calendar year 2024: 2.04 USD (partial) · 2025: 2.21 USD · 2026: 2.42 USD to date first distribution recorded in the three-year window: 2024-05-09

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is Sanofi ADR (SNY)?

Sanofi ADR trades as SNY on the US exchange (US) in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is SNY in a Closelooknet index?

Not currently — Sanofi ADR is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-09-26.

Where does SNY trade against its moving averages?

Downtrend stack: Trades -5.9% vs the 50-day and -6.6% vs the 200-day average, 17.6% below the 52-week high and +1.1% off the 52-week low. Computed from daily closes. As of 2026-09-25 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Sanofi ADR trade when bond yields rise?

Over the past year Sanofi ADR had a beta of 0.62 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 63% of US names. On the 10 sessions in which long bonds fell most it moved −1.11% on average, against −0.74% for the S&P 500. The "How it trades on rate days" block on this page carries the lines.

Where has Closelooknet written about Sanofi ADR?

Sanofi ADR appears in 1 Closelooknet piece, most recently Daily Pulse: Temperature 59 Risk-On as AW25 Surges 5.3% in Single Session (2026-04-16). What Closelooknet said most recently: The top names — MCD, XOM, UL, PLTR, SNY — span defensives, energy, and a single high-beta name in Palantir. (Daily Pulse, 2026-04-16). The "Mentioned on Closelooknet" block on this page lists the long reads, the reference entries and the dailies that name it.

What does Sanofi ADR do?

Sanofi researches, manufactures and sells medicines and vaccines across immunology, rare neurological disease, oncology and childhood immunisation, including combination vaccines for several infections at once. It also runs a wide set of collaborations with smaller biotech and computational firms, several of them using machine-learning platforms to search for new drug candidates. The company is based in Paris and was known as Sanofi-Aventis before it took its current name. Closelooknet has not assigned it a peer group; the comparison the market usually draws is with other large diversified drugmakers such as Pfizer.

Where does Sanofi ADR sit in the AI build-out?

Sanofi carries no seat in our index and sits outside the layered AI build-out that our index tracks; it belongs to the pharmaceuticals sleeve of the wider universe the diary follows for its own sake, not as an input to chips, data centres or models. It holds no seat in our index and no Closelooknet score module has been built for it. It has appeared once in the diary, in a Daily Pulse edition that named it among defensives alongside McDonald's, ExxonMobil and Unilever, with Palantir as the single high-beta name in that session.

Does Sanofi ADR pay a dividend?

Sanofi ADR has paid 2.42 USD per share over the last twelve months, paid once a year, a trailing yield of 5.89% on the 2026-09-25 close; the last distribution recorded in the price series was 2.42 USD on 2026-05-04. The "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Sanofi ADR recently?

The most recent analyst action on Sanofi ADR on the Closelooknet wire is a initiation by RBC Capital on 2026-09-08 (at Sector Perform). 1 action on the analyst wire since 2026-08-13: 1 initiation. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for SNY, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

then Drug Manufacturers - General, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.